Cargando…

2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies

BACKGROUND: Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group. MATERIAL AND METHODS: 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 implants in 13 healthy patients. Data measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Fierro, Manuel, Castellanos-Cosano, Lizett, Hueto-Madrid, Juan Antonio, López-Jiménez, Julián, Núñez-Vázquez, Ramiro José, Machuca-Portillo, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635626/
https://www.ncbi.nlm.nih.gov/pubmed/37099709
http://dx.doi.org/10.4317/medoral.25997
_version_ 1785146345304096768
author Pérez-Fierro, Manuel
Castellanos-Cosano, Lizett
Hueto-Madrid, Juan Antonio
López-Jiménez, Julián
Núñez-Vázquez, Ramiro José
Machuca-Portillo, Guillermo
author_facet Pérez-Fierro, Manuel
Castellanos-Cosano, Lizett
Hueto-Madrid, Juan Antonio
López-Jiménez, Julián
Núñez-Vázquez, Ramiro José
Machuca-Portillo, Guillermo
author_sort Pérez-Fierro, Manuel
collection PubMed
description BACKGROUND: Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group. MATERIAL AND METHODS: 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 implants in 13 healthy patients. Data measured through Lagervall-Jansson index (after surgery, at prosthetic loading, at 2 years). Statistics: Chi-square, Haberman’s, ANOVA, Mann-Whitney-U. Significance p<0.05. RESULTS: Haemorrhagic accidents in 2 coagulopathies patients (non-statistical differences). Hereditary coagulopathies patients suffered more hepatitis (p<0.05), HIV (p<0.05) and less previous periodontitis (p<0.01). Non-statistical differences in marginal bone loss among groups. 2 implants were lost in the hereditary coagulopathies and none in the control group (non-statistical differences). Hereditary coagulopathies patients had longer (p<0.001), and narrower implants (p<0.05) placed. 43.2% external prosthetic connection in hereditary coagulopathies patients (p<0.001); change of prosthetic platform more frequent in control group (p<0.05). 2 implants lost: external connection (p<0.05). Survival rate 96.8% (hereditary coagulopathies 94.6%, control group 100%). CONCLUSIONS: Implant and marginal bone loss at 2 years is similar in patients with hereditary coagulopathies and control group. Precautions should be taken on the treatment for hereditary coagulopathies patients, through prior haematological protocol. Implant loss only occurred in in a patient with Von-Willebrand´s disease. Key words:Dental implants, inherited coagulation disorders, haemophilia A/B, Von Willebrand disease, marginal bone loss.
format Online
Article
Text
id pubmed-10635626
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-106356262023-11-15 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies Pérez-Fierro, Manuel Castellanos-Cosano, Lizett Hueto-Madrid, Juan Antonio López-Jiménez, Julián Núñez-Vázquez, Ramiro José Machuca-Portillo, Guillermo Med Oral Patol Oral Cir Bucal Research BACKGROUND: Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group. MATERIAL AND METHODS: 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 implants in 13 healthy patients. Data measured through Lagervall-Jansson index (after surgery, at prosthetic loading, at 2 years). Statistics: Chi-square, Haberman’s, ANOVA, Mann-Whitney-U. Significance p<0.05. RESULTS: Haemorrhagic accidents in 2 coagulopathies patients (non-statistical differences). Hereditary coagulopathies patients suffered more hepatitis (p<0.05), HIV (p<0.05) and less previous periodontitis (p<0.01). Non-statistical differences in marginal bone loss among groups. 2 implants were lost in the hereditary coagulopathies and none in the control group (non-statistical differences). Hereditary coagulopathies patients had longer (p<0.001), and narrower implants (p<0.05) placed. 43.2% external prosthetic connection in hereditary coagulopathies patients (p<0.001); change of prosthetic platform more frequent in control group (p<0.05). 2 implants lost: external connection (p<0.05). Survival rate 96.8% (hereditary coagulopathies 94.6%, control group 100%). CONCLUSIONS: Implant and marginal bone loss at 2 years is similar in patients with hereditary coagulopathies and control group. Precautions should be taken on the treatment for hereditary coagulopathies patients, through prior haematological protocol. Implant loss only occurred in in a patient with Von-Willebrand´s disease. Key words:Dental implants, inherited coagulation disorders, haemophilia A/B, Von Willebrand disease, marginal bone loss. Medicina Oral S.L. 2023-11 2023-04-26 /pmc/articles/PMC10635626/ /pubmed/37099709 http://dx.doi.org/10.4317/medoral.25997 Text en Copyright: © 2023 Medicina Oral S.L. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Pérez-Fierro, Manuel
Castellanos-Cosano, Lizett
Hueto-Madrid, Juan Antonio
López-Jiménez, Julián
Núñez-Vázquez, Ramiro José
Machuca-Portillo, Guillermo
2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
title 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
title_full 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
title_fullStr 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
title_full_unstemmed 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
title_short 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
title_sort 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635626/
https://www.ncbi.nlm.nih.gov/pubmed/37099709
http://dx.doi.org/10.4317/medoral.25997
work_keys_str_mv AT perezfierromanuel 2yearsretrospectiveobservationalcasecontrolstudyonsurvivalandmarginalbonelossofimplantsinpatientswithhereditarycoagulopathies
AT castellanoscosanolizett 2yearsretrospectiveobservationalcasecontrolstudyonsurvivalandmarginalbonelossofimplantsinpatientswithhereditarycoagulopathies
AT huetomadridjuanantonio 2yearsretrospectiveobservationalcasecontrolstudyonsurvivalandmarginalbonelossofimplantsinpatientswithhereditarycoagulopathies
AT lopezjimenezjulian 2yearsretrospectiveobservationalcasecontrolstudyonsurvivalandmarginalbonelossofimplantsinpatientswithhereditarycoagulopathies
AT nunezvazquezramirojose 2yearsretrospectiveobservationalcasecontrolstudyonsurvivalandmarginalbonelossofimplantsinpatientswithhereditarycoagulopathies
AT machucaportilloguillermo 2yearsretrospectiveobservationalcasecontrolstudyonsurvivalandmarginalbonelossofimplantsinpatientswithhereditarycoagulopathies